Lam Research Corporation
LRCX
$873.62
-$15.30-1.72%
| Weiss Ratings | LRCX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Excellent | |||
| Risk Index | Fair | |||
| Risk Grade | C- | |||
| Reward Grade | A- | |||
| Rating Factors | LRCX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Weak | |||
| Growth Index | Good | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Good | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | LRCX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.75 | |||
| Price History | LRCX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -0.49% | |||
| 30-Day Total Return | -1.36% | |||
| 60-Day Total Return | 16.68% | |||
| 90-Day Total Return | 36.98% | |||
| Year to Date Total Return | 29.33% | |||
| 1-Year Total Return | 96.55% | |||
| 2-Year Total Return | 108.54% | |||
| 3-Year Total Return | 57.78% | |||
| 5-Year Total Return | 425.64% | |||
| 52-Week High % Change | -9.44% | |||
| 52-Week Low % Change | 88.97% | |||
| Price | LRCX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $1,007.39 | |||
| 52-Week Low Price | $482.74 | |||
| 52-Week Low Price (Date) | Apr 19, 2023 | |||
| 52-Week High Price (Date) | Mar 07, 2024 | |||
| Valuation | LRCX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 119.60B | |||
| Enterprise Value | 118.95B | |||
| Price/Earnings (TTM) | 35.27 | |||
| Earnings Per Share (TTM) | 25.87 | |||
| Earnings Per Share Growth | -30.47% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 8.42 | |||
| Price/Book (Q) | 14.56 | |||
| Enterprise Value/Revenue (TTM) | 8.31 | |||
| Price | $968.58 | |||
| Enterprise Value/EBITDA (TTM) | 27.12 | |||
| Enterprise Value/EBIT | 29.56 | |||
| Market Cap Category | Large Cap | |||
| Dividends and Shares | LRCX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 132.22M | |||
| Dividend Yield | 0.85% | |||
| Div. Per Share (Most Recent) | $2.00 | |||
| Dividend Per Share (TTM) | $7.73 | |||
| Payout Ratio (TTM) | 27.79% | |||
| Dividend Per Share (Most Recent) | $2.00 | |||
| Company Info | LRCX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 510 572 0200 | |||
| Address | 4650 Cushing Parkway Fremont, CA 94538 | |||
| Website | www.lamresearch.com | |||
| Country | United States | |||
| Year Founded | 1980 | |||
| Profitability | LRCX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 28.10% | |||
| Profit Margin | 24.15% | |||
| Management Effectiveness | LRCX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 13.24% | |||
| Return on Equity | 41.85% | |||
| Income Statement | LRCX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 14.32B | |||
| Total Revenue (TTM) | 14.32B | |||
| Revenue Per Share | $108.28 | |||
| Gross Profit (TTM) | 6.58B | |||
| EBITDA (TTM) | 4.39B | |||
| EBIT (TTM) | 4.02B | |||
| Net Income (TTM) | 3.46B | |||
| Net Income Avl. to Common (TTM) | 3.46B | |||
| Total Revenue Growth (Q YOY) | -28.79% | |||
| Earnings Growth (Q YOY) | -35.02% | |||
| EPS Diluted (TTM) | 25.87 | |||
| EPS Diluted Growth (Q YOY) | -32.96% | |||
| Balance Sheet | LRCX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 5.64B | |||
| Cash Per Share (Q) | $42.64 | |||
| Total Current Assets (Q) | 13.05B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 8.22B | |||
| Current Ratio (Q) | 3.056 | |||
| Book Value Per Share (Q) | $62.63 | |||
| Total Assets (Q) | 18.78B | |||
| Total Current Liabilities (Q) | 4.27B | |||
| Total Debt (Q) | 4.98B | |||
| Total Liabilities (Q) | 10.56B | |||
| Total Common Equity (Q) | 8.22B | |||
| Cash Flow | LRCX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -316.15M | |||
| Cash from Financing (TTM) | -4.04B | |||
| Net Change in Cash (TTM) | 889.46M | |||
| Levered Free Cash Flow (TTM) | 4.08B | |||
| Cash from Operations (TTM) | 5.25B | |||
